Clinical Trials Directory

Trials / Unknown

UnknownNCT04339946

Bidimensional Rectal-water Contrast-transvaginal Ultrasonography (2D-RWC-TVS) Versus 3D-RWC-TVS in the Diagnosis of Rectosigmoid Endometriosis

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (actual)
Sponsor
Ospedale Policlinico San Martino · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers

Summary

An accurate diagnosis of the presence, location and extent of the rectosigmoid endometriosis is of paramount importance for the clinicians in order to inform the patients on the potential surgical or medical treatments. It is well established that transvaginal ultrasonography is the first-line investigation in patients with suspicion of deep infiltrating endometriosis. An improvement in the performance of transvaginal ultrasonography in diagnosing rectosigmoid endometriosis may be obtained by using rectal water contrast during transvaginal ultrasonographic scan.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTThree-dimensional rectal water contrast transvaginal ultrasonography (3D-RWC-TVS)Rectal water contrast transvaginal ultrasonography is based on the distention of rectosigmoid with saline solution. Three-dimensional reconstructions convert standard 2D grayscale ultrasound acquisitions into a volumetric dataset.
DIAGNOSTIC_TESTTwo-dimensional rectal water contrast transvaginal ultrasonography (2D-RWC-TVS)Rectal water contrast transvaginal ultrasonography is based on the distention of rectosigmoid with saline solution.

Timeline

Start date
2018-01-01
Primary completion
2021-01-01
Completion
2022-03-01
First posted
2020-04-09
Last updated
2021-03-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04339946. Inclusion in this directory is not an endorsement.